Medicare-Paid Naloxone: Trends in Non-Metropolitan and Metropolitan Areas

Authors

Chris Delcher, University of KentuckyFollow
Yue Cheng, University of KentuckyFollow
Minji Sohn, University of KentuckyFollow
Jeffery C. Talbert, University of KentuckyFollow
Patricia R. Freeman, University of KentuckyFollow

Abstract

Overview of Key Findings

• Medicare pays for the largest share (> 30%) of naloxone dispensed from retail pharmacies in non-metropolitan areas.
• Medicare-paid dispensing has grown since 2013, but from 2017-2018 dispensing growth in non-metropolitan areas slowed considerably compared to metropolitan areas (42% v 121%, respectively).
• As of 2018, the rate of naloxone dispensing to Medicare enrollees in metropolitan areas was approximately double that in non-metropolitan areas (4.9 v 2.9 per 1,000 enrollees, respectively).

Publication Date

5-2021

Notes/Citation Information

© 2021 Rural & Underserved Health Research Center, University of Kentucky

The information, conclusions and opinions expressed in this document are those of the authors and no endorsement by FORHP, HRSA, HHS, or the University of Kentucky is intended or should be inferred.

Funding Information

This project was supported by the Federal Office of Rural Health Policy (FORHP), Health Resources and Services Administration (HRSA), U.S. Department of Health and Human Services (HHS) under cooperative agreement # U1CRH30041.

Repository Citation

Delcher, Chris; Cheng, Yue; Sohn, Minji; Talbert, Jeffery C.; and Freeman, Patricia R., "Medicare-Paid Naloxone: Trends in Non-Metropolitan and Metropolitan Areas" (2021). Rural & Underserved Health Research Center Publications. 18.
https://uknowledge.uky.edu/ruhrc_reports/18